These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1173537)

  • 21. Assessing pharmacokinetic and pharmacodynamic interactions in clinical trials of antiepileptic drugs.
    Reife RA
    Adv Neurol; 1998; 76():95-103. PubMed ID: 9408466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salicylate kinetics and dosage rationale.
    Med J Aust; 1972 Sep; 2(13):696. PubMed ID: 5084966
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacological interference of glibornuride with sulfaphenazole, phenylbutazone, and phenprocoumon in man].
    Eckhardt W; Rudolph R; Sauer H; Schubert WR; Undeutsch D
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2212. PubMed ID: 4679251
    [No Abstract]   [Full Text] [Related]  

  • 24. An analysis of the effect of hypoalbuminemia on the amount of free drug in plasma for drugs bound at two sets of sites.
    Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):681-8. PubMed ID: 4456500
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug interactions due to enzymatic inhibition. The predictive value of pharmacokinetic studies].
    Descotes J; Simonet R; Loupi E; Evreux JC
    Therapie; 1986; 41(5):349-51. PubMed ID: 3810522
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinically important interactions of nonsteroidal antiinflammatory drugs with other medications.
    Furst DE
    J Rheumatol Suppl; 1988 Oct; 17():58-62. PubMed ID: 2905007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Benzodiazepines. Factors altering pharmacokinetic parameters and drug interactions].
    Singlas E
    Encephale; 1983; 9(4 Suppl 2):67B-73B. PubMed ID: 6144532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of a pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity.
    Jamali F; Coutts RT; Malek F; Finer NN; Peliowski A
    Dev Pharmacol Ther; 1991; 16(2):78-82. PubMed ID: 1914782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug-drug interaction risk assessment.
    Venkatakrishnan K; Obach RS; Rostami-Hodjegan A
    Xenobiotica; 2007; 37(10-11):1225-56. PubMed ID: 17968744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetic aspects of anticonvulsant therapy with benzonal].
    Okudzhava VM; Chanvetadze BG; Antadze ZI; Chkhenkeli SI; Rukhadze MD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(6):49-52. PubMed ID: 3188749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salicylate pharmacokintics in the dog.
    McCann WP; Palmisano PA
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):17-25. PubMed ID: 4686099
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics of salicylates administered with metoprolol.
    Spahn H; Langguth P; Kirch W; Mutschler E; Ohnhaus EE
    Arzneimittelforschung; 1986 Nov; 36(11):1697-9. PubMed ID: 3814230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Criticism of pharmacokinetic clearance concepts.
    Keller F; Schoole J
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):563-8. PubMed ID: 6654532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrophotofluorometric determination of salicylamide in blood serum and urine.
    Veresh SA; Hom FS; Miskel JJ
    J Pharm Sci; 1971 Jul; 60(7):1092-5. PubMed ID: 5115255
    [No Abstract]   [Full Text] [Related]  

  • 35. Basic pharmacokinetic principles and their application to psychotropic drugs.
    Greenblatt DJ
    J Clin Psychiatry; 1993 Sep; 54 Suppl():8-13; discussion 55-6. PubMed ID: 8407859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The physiologic availability of solid dosage forms of phenylbutazone. II. Correlation of in vivo physiologic availability and in vitro dissolution parameters.
    Withey RJ; Feng H; Cook D; Van Petten GR; Lettau HF
    J Clin Pharmacol New Drugs; 1971; 11(3):187-96. PubMed ID: 5211352
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of chloramphenicol on serum salicylate concentrations in cats and dogs.
    Akesson CE; Linero PE
    Am J Vet Res; 1982 Aug; 43(8):1471-2. PubMed ID: 7103230
    [No Abstract]   [Full Text] [Related]  

  • 38. Proceedings: Changes of pharmacokinetic parameters of new antiinflammatory drugs influenced by drug interaction.
    Zathurecký L; Szelepcsényiová A; Bruncková E; Masaryková V; Hajnovic F
    Acta Pharm Suec; 1974 Dec; 11(6):654-5. PubMed ID: 1173537
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetics of certain drugs in the domesticated goat.
    Boulos BM; Jenkins WL; Davis LE
    Am J Vet Res; 1972 May; 33(5):943-52. PubMed ID: 5023053
    [No Abstract]   [Full Text] [Related]  

  • 40. [The tissue cage in dogs--a pharmacologic model for the representation of plasma and tissue kinetics].
    Scherkl R; Hashem A; Frey HH
    Dtsch Tierarztl Wochenschr; 1996 May; 103(5):174-7. PubMed ID: 8964239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.